Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.
作者信息
Renvoisé Aurélie, Brossier Florence, Galati Eve, Veziris Nicolas, Sougakoff Wladimir, Aubry Alexandra, Robert Jérôme, Cambau Emmanuelle, Jarlier Vincent, Bernard Christine
机构信息
Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France AP-HP, Hôpital Pitié-Salpêtrière, Bactériologie-Hygiène, Paris, France Sorbonne Universités, UPMC Université de Paris 06, U1135, Centre for Immunology and Microbial Infections, Team 13, Paris, France INSERM, U1135, Centre for Immunology and Microbial Infections, Team 13, Paris, France.
Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France AP-HP, Hôpital Pitié-Salpêtrière, Bactériologie-Hygiène, Paris, France.
出版信息
Antimicrob Agents Chemother. 2015 Nov;59(11):7153-5. doi: 10.1128/AAC.01027-15. Epub 2015 Aug 31.
Abstract
摘要
相似文献
1
Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.评估鸟分枝杆菌复合体感染中对克拉霉素和阿米卡星的原发性和继发性耐药性。
Antimicrob Agents Chemother. 2015 Nov;59(11):7153-5. doi: 10.1128/AAC.01027-15. Epub 2015 Aug 31.
2
GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.GenoType NTM-DR 检测试剂盒鉴定鸟分枝杆菌复合群和脓肿分枝杆菌及检测克拉霉素和阿米卡星耐药性的性能评估。
J Clin Microbiol. 2019 Jul 26;57(8). doi: 10.1128/JCM.00516-19. Print 2019 Aug.
3
[Antimicrobial susceptibility and genotyping of ].[抗菌药敏性及基因分型]。
你提供的原文似乎不完整，若有完整内容请随时告知我以便更准确翻译。
Zhonghua Jie He He Hu Xi Za Zhi. 2018 Jul 12;41(7):539-543. doi: 10.3760/cma.j.issn.1001-0939.2018.07.007.
4
Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates.评价一种快速检测鸟分枝杆菌复合群分离株克拉霉素耐药基因的方法。
J Antimicrob Chemother. 2011 Apr;66(4):722-9. doi: 10.1093/jac/dkq536. Epub 2011 Feb 3.
5
Isolation and characterizations of clarithromycin-resistant Mycobacterium avium clinical isolates.克拉霉素耐药鸟分枝杆菌临床分离株的分离与鉴定。
J Clin Lab Anal. 2011;25(1):33-6. doi: 10.1002/jcla.20403.
6
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.氯法齐明可预防暴露于阿米卡星和克拉霉素的脓肿分枝杆菌和鸟分枝杆菌标准菌株的再生长。
Antimicrob Agents Chemother. 2015 Dec 7;60(2):1097-105. doi: 10.1128/AAC.02615-15. Print 2016 Feb.
7
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.基于全基因组测序的泰国鸟分枝杆菌复合体分离株表型药物敏感性谱和遗传分析。
PLoS One. 2023 Nov 22;18(11):e0294677. doi: 10.1371/journal.pone.0294677. eCollection 2023.
8
Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.从接受含克拉霉素治疗方案的艾滋病患者中分离出的克拉霉素敏感和耐药鸟分枝杆菌菌株的比较。
J Infect. 2000 Jan;40(1):49-54. doi: 10.1053/jinf.1999.0539.
9
Comparison of in vitro synergistic effect between clarithromycin or azithromycin in combination with amikacin against Mycobacterium intracellulare.比较克拉霉素或阿奇霉素与阿米卡星联合应用对细胞内分枝杆菌的体外协同作用。
J Glob Antimicrob Resist. 2019 Sep;18:183-186. doi: 10.1016/j.jgar.2019.03.017. Epub 2019 Apr 3.
10
Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration.通过突变预防浓度测定的各种抗生素对鸟分枝杆菌-胞内分枝杆菌的有效性。
Int J Antimicrob Agents. 2005 Mar;25(3):221-5. doi: 10.1016/j.ijantimicag.2004.09.018. Epub 2005 Jan 21.
引用本文的文献
1
Risk factors, molecular analysis and treatment outcomes of amikacin-resistant complex pulmonary disease.耐阿米卡星复杂性肺部疾病的危险因素、分子分析及治疗结果
ERJ Open Res. 2025 Aug 11;11(4). doi: 10.1183/23120541.01084-2024. eCollection 2025 Jul.
2
Drug susceptibility profiles of isolated in the state of São Paulo, 2008-2024.2008年至2024年在圣保罗州分离出的菌株的药敏谱。
J Med Microbiol. 2025 Apr;74(4). doi: 10.1099/jmm.0.002005.
3
Effects of Amikacin Liposome Inhalation Suspension and Amikacin Resistance Development in Patients With Refractory Complex Pulmonary Disease.阿米卡星脂质体吸入混悬液对难治性复杂性肺部疾病患者的影响及阿米卡星耐药性的发展
Open Forum Infect Dis. 2025 Mar 1;12(3):ofaf118. doi: 10.1093/ofid/ofaf118. eCollection 2025 Mar.
4
Characterisation and antimicrobial susceptibility pattern of non-tuberculous mycobacteria.非结核分枝杆菌的特征及抗菌药敏模式
S Afr J Infect Dis. 2024 Jan 5;39(1):525. doi: 10.4102/sajid.v39i1.525. eCollection 2024.
5
MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study.MGIT-seq 技术用于鉴定非结核分枝杆菌及其耐药性：一项前瞻性研究。
J Clin Microbiol. 2023 Apr 20;61(4):e0162622. doi: 10.1128/jcm.01626-22. Epub 2023 Mar 22.
6
Insights on the relationship between structure vs. toxicological activity of antibacterial rhodamine-labelled 3-hydroxy-4-pyridinone iron(III) chelators in HepG2 cells.关于抗菌罗丹明标记的3-羟基-4-吡啶酮铁（III）螯合剂在HepG2细胞中的结构与毒理学活性之间关系的见解。
Interdiscip Toxicol. 2018 Oct;11(3):189-199. doi: 10.2478/intox-2018-0016. Epub 2019 Oct 18.
7
Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.临床和环境分枝杆菌嵌合体分离株的抗菌药敏性。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00755-19. Print 2019 Sep.
8
GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.GenoType NTM-DR 检测试剂盒鉴定鸟分枝杆菌复合群和脓肿分枝杆菌及检测克拉霉素和阿米卡星耐药性的性能评估。
J Clin Microbiol. 2019 Jul 26;57(8). doi: 10.1128/JCM.00516-19. Print 2019 Aug.
本文引用的文献
1
Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.鸟分枝杆菌与胞内分枝杆菌之间的药敏分布存在显著差异。
J Clin Microbiol. 2014 Dec;52(12):4439-40. doi: 10.1128/JCM.02127-14. Epub 2014 Oct 1.
2
In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.体外研究阿米卡星对结核分枝杆菌复合群分离株的活性，提出了 MIC 折点，并发现了治疗分离株中 16S rRNA 基因突变。
J Clin Microbiol. 2013 Oct;51(10):3389-94. doi: 10.1128/JCM.01612-13. Epub 2013 Aug 14.
3
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.从肺部样本中分离的非结核分枝杆菌的地理多样性：一项 NTM-NET 合作研究。
Eur Respir J. 2013 Dec;42(6):1604-13. doi: 10.1183/09031936.00149212. Epub 2013 Apr 18.
4
Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.通过 erm(41) 和 rrl 测序评估脓肿分枝杆菌属菌株对克拉霉素的敏感性。
Antimicrob Agents Chemother. 2011 Feb;55(2):775-81. doi: 10.1128/AAC.00861-10. Epub 2010 Dec 6.
5
The role of efflux pumps in macrolide resistance in Mycobacterium avium complex.外排泵在鸟分枝杆菌复合体中对大环内酯类耐药的作用。
Int J Antimicrob Agents. 2009 Dec;34(6):529-33. doi: 10.1016/j.ijantimicag.2009.07.010. Epub 2009 Sep 8.
6
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.美国胸科学会/美国感染病学会官方声明：非结核分枝杆菌病的诊断、治疗与预防
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
7
Natural and acquired macrolide resistance in mycobacteria.分枝杆菌的天然和获得性大环内酯耐药性。
Curr Drug Targets Infect Disord. 2002 Dec;2(4):355-70. doi: 10.2174/1568005023342263.
8
Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex.鸟分枝杆菌胞内菌复合群中克拉霉素耐药的分子基础。
Tuber Lung Dis. 2000;80(1):1-4. doi: 10.1054/tuld.1999.0227.
9
Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.从艾滋病患者和米色小鼠中分离出的鸟分枝杆菌复合群菌株在克拉霉素治疗期间获得的耐药性。
J Antimicrob Chemother. 1995 Jul;36(1):129-36. doi: 10.1093/jac/36.1.129.
Zotero 插件